{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:56:24Z","timestamp":1781754984654,"version":"3.54.5"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["2019-AARG-NTF-644507"],"award-info":[{"award-number":["2019-AARG-NTF-644507"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS126584"],"award-info":[{"award-number":["R01NS126584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS10019"],"award-info":[{"award-number":["R01 NS10019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG083625"],"award-info":[{"award-number":["RF1 AG083625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nbd.2025.107246","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:37:42Z","timestamp":1766594262000},"page":"107246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in mice"],"prefix":"10.1016","volume":"218","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bridgeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden A.","family":"Noblet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette M.","family":"Amundsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjoon","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107246_bb0005","doi-asserted-by":"crossref","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","article-title":"The gene ontology knowledgebase in 2023","volume":"224","author":"Aleksander","year":"2023","journal-title":"Genetics"},{"key":"10.1016\/j.nbd.2025.107246_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE-related risk of developing Alzheimer disease","volume":"75","author":"Altmann","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0015","first-page":"333","article-title":"Hippocampal epilepsy produced by ouabain: studies of cerebral circulation and ionic metabolism","volume":"9","author":"Baldy-Moulinier","year":"1973","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0020","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221137","article-title":"A \u201cmulti-omics\u201d analysis of blood\u2013brain barrier and synaptic dysfunction in APOE4 mice","volume":"219","author":"Barisano","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2025.107246_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal dementia","volume":"60","author":"Beagle","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbd.2025.107246_bb0030","first-page":"1091","article-title":"A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009"},{"key":"10.1016\/j.nbd.2025.107246_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","article-title":"Cell type-specific roles of APOE4 in Alzheimer disease","volume":"25","author":"Blumenfeld","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.107246_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.55.3.435","article-title":"APOE \u03b54 genotype is associated with an earlier onset of chronic temporal lobe epilepsy","volume":"55","author":"Briellmann","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107246_bb0045","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI129987","article-title":"Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases","volume":"129","author":"Cai","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.107246_bb0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuropharm.2007.06.017","article-title":"Modafinil exerts a dose-dependent antiepileptic effect mediated by adrenergic \u03b11 and histaminergic H1 receptors in mice","volume":"53","author":"Chen","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.107246_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nchembio.1657","article-title":"Terazosin activates Pgk1 and Hsp90 to promote stress resistance","volume":"11","author":"Chen","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2025.107246_bb0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1124\/pr.119.017392","article-title":"Sex differences in the epilepsies and associated comorbidities: implications for use and development of pharmacotherapies","volume":"72","author":"Christian","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2025.107246_bb0065","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaneurol.2025.0013","article-title":"Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis","volume":"82","author":"Coughlan","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","article-title":"Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD","volume":"65","author":"Dickerson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107246_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnsyn.2016.00023","article-title":"The postsynaptic density: there is more than meets the eye","volume":"8","author":"Dosemeci","year":"2016","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.nbd.2025.107246_bb0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41398-021-01631-0","article-title":"APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline","volume":"11","author":"Fang","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107246_bb0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1528-1157.1995.tb00999.x","article-title":"Differential susceptibility to seizures induced by systemic kainic acid treatment in mature DBA\/2J and C57BLl6J mice","volume":"36","author":"Ferraro","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2025.107246_bb0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease\u2014the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.0013-9580.2005.15804.x","article-title":"ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy","volume":"46","author":"Gambardella","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2025.107246_bb0100","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy","volume":"33","author":"Holth","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107246_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2012.05.048","article-title":"Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice","volume":"1467","author":"Hunter","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.107246_bb0110","doi-asserted-by":"crossref","first-page":"18227","DOI":"10.1523\/JNEUROSCI.3266-12.2012","article-title":"Apolipoprotein E, not fibrillar \u03b2-amyloid, reduces cerebral glucose metabolism in normal aging","volume":"32","author":"Jagust","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107246_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.107246_bb0120","article-title":"Interrogating functional connectivity of in vitro neural glia tissue model modulated through integrative control of matrix stiffness and a neurotrophic factor","volume":"123699","author":"Kang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.nbd.2025.107246_bb0125","article-title":"Glycolysis: a multifaceted metabolic pathway and signalling hub","volume":"107906","author":"Kierans","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107246_bb0130","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107246_bb0135","doi-asserted-by":"crossref","first-page":"eadn6016","DOI":"10.1126\/sciadv.adn6016","article-title":"Phosphoglycerate kinase is a central leverage point in Parkinson\u2019s disease\u2013driven neuronal metabolic deficits","volume":"10","author":"Kokotos","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2025.107246_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(90)90243-5","article-title":"Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs","volume":"526","author":"Kosobud","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.107246_bb0145","article-title":"APOE4 promotes tonic-clonic seizures, an effect modified by familial Alzheimer\u2019s disease mutations","volume":"9","author":"Lamoureux","year":"2021","journal-title":"Fron. Cell Develop. Biol."},{"key":"10.1016\/j.nbd.2025.107246_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yebeh.2019.06.015","article-title":"Association of apolipoprotein E genotypes with epilepsy risk: a systematic review and meta-analysis","volume":"98","author":"Liang","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nbd.2025.107246_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101676","article-title":"ATP-sensitive potassium channels: a double-edged sword in neurodegenerative diseases","volume":"80","author":"Lv","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2025.107246_bb0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2018.00274","article-title":"Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof","volume":"12","author":"McDonald","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2025.107246_bb0165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81645","article-title":"The Na(+)\/K(+) pump dominates control of glycolysis in hippocampal dentate granule cells","volume":"11","author":"Meyer","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2025.107246_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clini. Pharm."},{"key":"10.1016\/j.nbd.2025.107246_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0324-6","article-title":"Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease","volume":"14","author":"Najm","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107246_bb0180","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41467-017-01444-0","article-title":"Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology","volume":"8","author":"Nuriel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107246_bb0185","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5698\/1535-7597.18.5.318","article-title":"A metabolic paradigm for epilepsy","volume":"18","author":"Patel","year":"2018","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.nbd.2025.107246_bb0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10799893.2010.550008","article-title":"Cardiac and neuroprotection regulated by \u03b11-adrenergic receptor subtypes","volume":"31","author":"Perez","year":"2011","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.nbd.2025.107246_bb0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1157.1973.tb03961.x","article-title":"The epileptogenic effect of ouabain (g-strophanthin) its action on the EEG and cortical morphology","volume":"14","author":"Petsche","year":"1973","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2025.107246_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2004.08.002","article-title":"Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3\u03b1-androstanediol and 17\u03b2-estradiol","volume":"129","author":"Reddy","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.107246_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00001756-200403010-00026","article-title":"Anticonvulsant activity of the testosterone-derived neurosteroid 3\u03b1-androstanediol","volume":"15","author":"Reddy","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2025.107246_bb0210","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1523\/JNEUROSCI.21-17-06532.2001","article-title":"Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat","volume":"21","author":"Rudick","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107246_bb0215","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0337-20.2021","article-title":"The kainic acid models of temporal lobe epilepsy","volume":"8","author":"Rusina","year":"2021","journal-title":"Eneuro"},{"key":"10.1016\/j.nbd.2025.107246_bb0220","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.aaa1299","article-title":"Targeting LDH enzymes with a stiripentol analog to treat epilepsy","volume":"347","author":"Sada","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107246_bb0225","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2025.107246_bb0230","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145112","article-title":"Parkinson disease among patients treated for benign prostatic hyperplasia with \u03b1 1 adrenergic receptor antagonists","volume":"131","author":"Sasane","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.107246_bb0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2021.11.022","article-title":"A pilot to assess target engagement of terazosin in Parkinson\u2019s disease","volume":"94","author":"Schultz","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107246_bb0240","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.107246_bb0245","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awy022","article-title":"Cognition and dementia in older patients with epilepsy","volume":"141","author":"Sen","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107246_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0255","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107246_bb0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamaneurol.2020.5157","article-title":"Association of glycolysis-enhancing alpha-1 blockers with risk of developing Parkinson disease","volume":"78","author":"Simmering","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0265","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/acn3.51881","article-title":"Glycolytic lactate production supports status epilepticus in experimental animals","volume":"10","author":"Skwarzynska","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2014.08.014","article-title":"The storm before the quiet: neuronal hyperactivity and a\u03b2 in the presymptomatic stages of Alzheimer\u2019s disease","volume":"36","author":"Stargardt","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107246_bb0275","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","article-title":"Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis","volume":"272","author":"Sullivan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107246_bb0280","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/cns.13893","article-title":"The role of Na+-K+-ATPase in the epileptic brain","volume":"28","author":"Sun","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2025.107246_bb0285","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.107246_bb0290","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamaneurol.2023.0339","article-title":"Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors","volume":"80","author":"Tai","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0295","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype?","volume":"12","author":"Targa Dias Anastacio, H","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107246_bb0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0305","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/epi.17192","article-title":"Pharmacological inhibition of STriatal-enriched protein tyrosine phosphatase by TC-2153 reduces hippocampal excitability and seizure propensity","volume":"63","author":"Walters","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2025.107246_bb0310","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-023-00477-1","article-title":"Glycolysis-enhancing \u03b11-adrenergic antagonists modify cognitive symptoms related to Parkinson\u2019s disease","volume":"9","author":"Weber","year":"2023","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.nbd.2025.107246_bb0315","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1464-4096.2001.02537.x-i1","article-title":"Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects","volume":"89","author":"Wilt","year":"2002","journal-title":"BJU Int."},{"key":"10.1016\/j.nbd.2025.107246_bb0320","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.107246_bb0325","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuroscience.2022.06.034","article-title":"Androgens regulate tau phosphorylation through phosphatidylinositol 3-kinase\u2013protein kinase B\u2013glycogen synthase kinase 3\u03b2 signaling","volume":"568","author":"Yao","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.107246_bb0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107246_bb0335","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.3390\/cells11244075","article-title":"Recent advances in the study of Na+\/K+-ATPase in neurodegenerative diseases","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.107246_bb0340","doi-asserted-by":"crossref","first-page":"2306826","DOI":"10.1002\/advs.202306826","article-title":"Mind in vitro platforms: versatile, scalable, robust, and open solutions to interfacing with living neurons","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125004632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125004632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:48:05Z","timestamp":1781754485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125004632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":68,"alternative-id":["S0969996125004632"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107246","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107246"}}